In this study, upregulated inflammasome activation enriches TAMs' recruitment to suppress CD8+ T cell activation in Brca1 mutant mammary tumors; thus, inhibition of inflammasome activation could postpone tumor relapse and block lung metastasis after surgically removing primary cancers. The gene discussed is CD8A; the disease is breast cancer.